Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Myelodysplastic following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA)

Leukemia volume 11, page 170 (1997)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. SH Kroft
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MS Tallman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. JM Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Thangavelu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. LA Peterson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kroft, S., Tallman, M., Shaw, J. et al. Myelodysplastic following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA). Leukemia 11, 170 (1997). https://doi.org/10.1038/sj.leu.2400523

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2400523

This article is cited by

Search

Advanced search

Quick links